Role of intravascular ERO1@ in acute lung injury
Role of intravascular ERO1@ in acute lung injury
批准号:
10267181
负责人:
Jaehyung Cho
金额:
$38.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-21 至 2024-08-31
关键词:
AcuteAcute Lung InjuryAddressAdhesionsAdhesivesAdmission activityAdult Respiratory Distress SyndromeAffectAlveolarAntibodiesAttenuatedBindingBiochemicalBiologicalBiological MarkersBloodBlood CellsBlood PlateletsBlood VesselsCell AggregationCell CommunicationCellsComplexComplicationDataDiseaseDisease ProgressionEndoplasmic ReticulumEndothelial CellsExtracellular ProteinGeneticGlycoproteinsGoalsHematological DiseaseHypoxiaImaging TechniquesImpairmentInflammationInflammatoryIntegrinsIntensive Care UnitsLeukocytesLifeLigand BindingLigandsLightLungLung InflammationMacrophage-1 AntigenMediatingMolecularMusNatural ImmunityNeutrophil InfiltrationOrgan failureOxidasesPathogenesisPathologicPathologyPatientsPeptidesPlasmaPneumoniaProcessProtein Disulfide IsomerasePulmonary EdemaPulmonary Valve InsufficiencyRoleSepsisSeveritiesSeverity of illnessSignal TransductionSiteSulfhydryl CompoundsSupporting CellSurfaceTestingTissuesTraumaadhesion receptorbasedesigndisulfide bondextracellularimaging approachimprovedinhibitor/antagonistinsightintravital imaginglung imagingmouse modelneutrophilnovelnovel therapeutic interventionnovel therapeuticsreceptorrecruitsepticsmall moleculetherapeutically effectivethromboinflammationvascular inflammation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Acute lung injury (ALI) is a life-threatening condition, which affects > 200,000 patients annually in the U.S. It is
associated with pneumonia, sepsis, and trauma, leading to pulmonary insufficiency and eventually multisystem
organ failure. Since excessive recruitment of activated neutrophils to lung microvessels is a primary cause of
ALI, a better understanding of the mechanism mediating neutrophil-endothelial cell interactions will provide
insight into developing an effective therapeutic for treating ALI. We previously demonstrated that intravascular
protein disulfide isomerase (PDI) enhances the ligand-binding activity of neutrophil and platelet surface receptors
and leads to intravascular cell-cell interactions during vascular inflammation. To elucidate how extracellular PDI
activity is regulated and whether the regulatory mechanism contributes to the pathology of ALI, we have found
that endoplasmic reticulum oxidoreductin 1α (ERO1α, a key oxidase of PDI in the ER) promotes neutrophil
recruitment during vascular inflammation. In this proposal, we will test the hypothesis that intravascular ERO1α
enhances the ligand-binding function of neutrophil adhesion receptors by modifying disulfide bonds, inducing
neutrophil recruitment to sites of acute lung inflammation. In Aim 1, we will determine the mechanism by which
ERO1α regulates neutrophil-endothelial cell interactions. In Aim 2, we will utilize lung live imaging techniques to
investigate the pathological role of intravascular ERO1α in ALI. In Aim 3, using the blood of patients with acute
respiratory distress syndrome (ARDS), we will determine the contribution of ERO1α to the disease progression
and severity in patients with ARDS. These studies will employ biochemical, cell biological, genetic, and confocal
intravital imaging approaches. Since little is known about extracellular thiol-modifying machinery, the proposed
studies will identify an essential, yet unexplored, mechanism that promotes the pathogenesis of ALI/ARDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes
-
批准号:10765748
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2023
-
负责人:Jaehyung Cho
-
依托单位:
ERO1 alpha in platelet activity and thrombosis
-
批准号:10321687
-
项目类别:
-
资助金额:$43.72万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Identification of an inhibitor of PDI-GPIbalpha signaling as a novel antithromboinflammatory agent
-
批准号:10242945
-
项目类别:
-
资助金额:$55.13万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Identification of an inhibitor of PDI-GPIbalpha signaling as a novel antithromboinflammatory agent
-
批准号:10253656
-
项目类别:
-
资助金额:$55.13万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
ERO1 alpha in platelet activity and thrombosis
-
批准号:10285785
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Role of intravascular ERO1@ in acute lung injury
-
批准号:10686908
-
项目类别:
-
资助金额:$41.33万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Ero1α in platelet activity and thrombosis
-
批准号:9884277
-
项目类别:
-
资助金额:$45.91万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Role of intravascular ERO1@ in acute lung injury
-
批准号:10469645
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Role of intravascular ERO1@ in acute lung injury
-
批准号:10027023
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
ERO1 alpha in platelet activity and thrombosis
-
批准号:10621694
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2020
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases and ERO1α in sickle cell vaso-occlusion
-
批准号:9977272
-
项目类别:
-
资助金额:$18.05万
-
财政年份:2019
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases and ERO1 alpha in sickle cell vaso-occlusion
-
批准号:10285800
-
项目类别:
-
资助金额:$29.15万
-
财政年份:2019
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases and ERO1 alpha in sickle cell vaso-occlusion
-
批准号:10426216
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2019
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases and ERO1 alpha in sickle cell vaso-occlusion
-
批准号:10191025
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2019
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases in neutrophil recruitment and thromboinflammatory disease
-
批准号:10295199
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases in neutrophil recruitment and thromboinflammatory disease
-
批准号:10414129
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2016
-
负责人:Jaehyung Cho
-
依托单位:
Neutrophil-platelet interactions during vascular inflammation
-
批准号:9173973
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2016
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases in neutrophil recruitment and thromboinflammatory disease
-
批准号:10284732
-
项目类别:
-
资助金额:$39.4万
-
财政年份:2016
-
负责人:Jaehyung Cho
-
依托单位:
Thiol isomerases in neutrophil recruitment and thromboinflammatory disease
-
批准号:10649685
-
项目类别:
-
资助金额:$41.55万
-
财政年份:2016
-
负责人:Jaehyung Cho
-
依托单位:
Protein disulfide isomerase in neutrophil recruitment and vascular inflammation
-
批准号:8899366
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2011
-
负责人:Jaehyung Cho
-
依托单位:
海外基金